RMC-6236-401 Expanded access program to treat patients with previously treated metastatic Pancreatic adenocarcinoma with Daraxonrasib



Mary Beth Wilwerding, RN Admin@NEcancertrials.com



Available at Nebraska Cancer Specialists, Omaha, NE locations and coming soon to Cancer Partners of Nebraska, Lincoln and Kearney, NE locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*

Email*

Phone*

Message*